Oki (Ketoprofen Lysine)

Ketoprofen lysine, the active ingredient in Oki, is a non‑steroidal anti‑inflammatory drug presented as a 50 mg tablet for oral use. It is indicated for the short‑term relief of mild to moderate pain and inflammation in adults. GNH USA supplies Oki as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ketoprofen lysine is a NSAID that reduces inflammation and pain in several musculoskeletal conditions. - Rheumatoid arthritis: helps reduce joint swelling and pain, improving mobility. - Osteoarthritis: alleviates chronic joint discomfort and stiffness. - Acute musculoskeletal injury: provides short‑term relief of pain and inflammation after sprains, strains or bruises. - Post‑operative pain: assists in managing pain following minor surgical procedures. - Dysmenorrhea: lessens menstrual‑related pelvic pain.

Ketoprofen lysine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal discomfort, such as nausea, dyspepsia or heartburn. - Headache. - Dizziness. - Mild skin rash or itching. - Elevated liver enzymes.

Serious or Rare Side Effects: - Peptic ulcer disease or gastrointestinal bleeding. - Severe skin reactions such as Stevens‑Johnson syndrome. - Hepatotoxicity or significant liver injury. - Renal impairment or acute kidney injury. - Anaphylactic shock or severe allergic reactions.

When using Ketoprofen lysine, certain precautions should be observed to minimise risk. - Assess risk for gastrointestinal bleeding: patients with a history of ulcers or chronic NSAID use should be monitored. - Monitor for cardiovascular events: especially if the patient has pre‑existing heart disease. - Evaluate renal function before treatment and periodically if the patient is elderly or has c  c   g g

t t t

t t

t.

t.

t.

",